BIOLEXIS Trademark

Trademark Overview

On Wednesday, April 1, 2026, a trademark application was filed for BIOLEXIS with the United States Patent and Trademark Office. The USPTO has given the BIOLEXIS trademark a serial number of 99739201. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 1, 2026. This trademark is owned by Biolexis Therapeutics, Inc.. The BIOLEXIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of type 2 diabetes; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of sarcopenia; pharmaceutical preparations for the treatment of muscle wasting diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of cancer

Research and development in the field of pharmaceuticals; research and development of new pharmaceutical products; scientific research in the nature of conducting clinical trials in the field of metabolic diseases; scientific research and development in the field of small molecule drugs
biolexis

General Information

Serial Number99739201
Word MarkBIOLEXIS
Filing DateWednesday, April 1, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, April 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkBIO LEXIS
Goods and ServicesPharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of type 2 diabetes; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of sarcopenia; pharmaceutical preparations for the treatment of muscle wasting diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of cancer
Goods and ServicesResearch and development in the field of pharmaceuticals; research and development of new pharmaceutical products; scientific research in the nature of conducting clinical trials in the field of metabolic diseases; scientific research and development in the field of small molecule drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 1, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 1, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiolexis Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLehi, UT 84043
US

Trademark Events

Event DateEvent Description
Wednesday, April 1, 2026NEW APPLICATION ENTERED
Wednesday, April 1, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

biolexis pharmaceutical treatment preparations diseases research development field metabolic scientific products